Laprophan Share Sale Draws Near Seven Times Demand in Casablanca
1 report, 1 independent
Updated Fri 10:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Laprophan, a Moroccan drug maker, conducted a share sale in Casablanca that drew provisional orders worth about MAD 15.3 billion. The offer was capped at MAD 2.22 billion, meaning demand was nearly seven times the number of shares available. The shares are scheduled to begin trading on the Casablanca Stock Exchange on November 25, 2026.
From riotimesonline.com
Why it matters
The successful capital increase provides funding for Laprophan. The company reported 2025 consolidated revenue of MAD 1.82 billion and a net profit of MAD 109 million, which represented a 33.9% increase.
From riotimesonline.com
Who's involved
- LaprophanMoroccan drug maker conducting the share sale and listing.
- MoroccoSovereign state where Laprophan operates and the market is located.
- CasablancaLocation of the Casablanca Stock Exchange where the shares will be listed.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.